These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8003818)

  • 21. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
    Jin Y; Burns FJ; Garte SJ
    Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
    Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
    Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
    Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
    J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative detection of amplification of proto-oncogenes in breast cancer.
    Chen Y; Dong J; Lu Y; McGee JO
    Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
    Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
    Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
    Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars].
    Hu Z; Lou L; Luo S
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 May; 18(3):165-7. PubMed ID: 12189705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
    Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
    Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.
    Candlish W; Kerr IB; Simpson HW
    J Pathol; 1986 Nov; 150(3):163-7. PubMed ID: 3027290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
    Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
    Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
    Spandidos DA; Field JK; Agnantis NJ; Evan GI; Moore JP
    Anticancer Res; 1989; 9(4):821-6. PubMed ID: 2683996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of c-myc proto-oncogene in primary human breast carcinomas.
    Pavelic ZP; Steele P; Preisler HD
    Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amplification, rearrangement and expression of the c-myc and c-Ha-ras1 proto-oncogenes in patients with breast cancer].
    Nikiforova IF
    Eksp Onkol; 1988; 10(1):17-20. PubMed ID: 3286221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.